戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sing AlgB.D59N or H-AlgB delta1-145 remained mucoid.
2 lony morphology and phenotype referred to as mucoid.
3 s in cystic fibrosis patients are frequently mucoid.
4 ved on solid culture media is referred to as mucoid.
5 monas aeruginosa (PA) as either nonmucoid or mucoid.
6 se-negative lasB::Cm knock-out mutant in the mucoid 8821 background was constructed, and it showed a
7 aeruginosa from cystic fibrosis patients are mucoid (alginate producing) yet lack flagella.
8                   Developing biofilms of the mucoid (alginate-producing) cystic fibrosis pulmonary is
9 s in Pseudomonas aeruginosa, are elevated in mucoid, alginate-producing bacteria and in response to i
10 ranscribed in response to iron limitation in mucoid, alginate-producing bacteria.
11                        We demonstrate that a mucoid, alginate-producing strain of Pseudomonas aerugin
12                 The resulting strain was non-mucoid and exhibited no detectable algD transcription.
13                                   A dominant mucoid and hypermutator mutL lineage was replaced after
14    To detect spontaneous mutations in csrRS, mucoid and large colony variants of M1 strain MGAS166 we
15 e &gland, brain, muscle, immune, metabolism, mucoid and nerve conduction.
16 ate that elastase, when overproduced in both mucoid and non-mucoid cells, stimulates alginate synthes
17  serotype A), the switching occurred between mucoid and nonmucoid colonies.
18 imary clinical B. pseudomallei isolates with mucoid and nonmucoid colony morphologies from the same s
19 table for all of the agents tested, for both mucoid and nonmucoid isolates.
20  fibrosis pulmonary isolate FRD1, as well as mucoid and nonmucoid mutant strains, were monitored by A
21 s associated with ARF in the SLC region, 964 mucoid and nonmucoid pharyngeal isolates recovered in SL
22 t in addition to being intracellular in both mucoid and nonmucoid Pseudomonas aeruginosa, Ndk is also
23  found to promote phagocytic killing of both mucoid and nonmucoid strains as well as protection again
24                As expected, a rocA mutant is mucoid and produces more transcript from the has promote
25 be difficult because the organisms are often mucoid and slow growing.
26  study, we observed that in CF isolates, the mucoid and the nonmotile phenotypes occur predominantly
27 robial susceptibilities of 48 CF strains (25 mucoid) and 50 non-CF strains to 12 anti-Pseudomonas age
28 ny size (large, medium, and small) and their mucoid appearance on blood agar.
29 sed HCN production in an alginate-producing (mucoid) background.
30 ious reports of increased algR expression in mucoid backgrounds, and RpoS additionally plays a role i
31 also are cotranscribed in both nonmucoid and mucoid backgrounds.
32                More importantly, HNO2 killed mucoid bacteria (a) in anaerobic biofilms; (b) in vitro
33                            Here we show that mucoid bacteria perish during anaerobic exposure to 15 m
34                     Increased proportions of mucoid bacteria were isolated during exacerbations occur
35 bits and elicited opsonic antibodies against mucoid but not nonmucoid P. aeruginosa, but nonetheless
36 X-treated mice also had dramatically reduced mucoid cell hyperplasia, and airway responsiveness retur
37  peribronchial eosinophilic infiltration and mucoid cell hyperplasia.
38 -kDa Ndk-Scs complex specifically present in mucoid cell predominantly synthesizes GTP and UTP but no
39 omplex media but is greatly reduced when the mucoid cells are grown in mineral salts media or in pres
40 osa is greatly reduced in alginate-secreting mucoid cells isolated from the lungs of cystic fibrosis
41                                           In mucoid cells of P. aeruginosa, Ndk is also known to exis
42 22) P. aeruginosa strains were compared, the mucoid cells were cleared several-fold less efficiently
43 se, when overproduced in both mucoid and non-mucoid cells, stimulates alginate synthesis.
44  In contrast, Scnn1b-Tg mice infected with a mucoid CF isolate carried high bacterial burdens, produc
45                   We sequenced algK from the mucoid CF isolate FRD1 and expressed it in Escherichia c
46 otype of an DeltaalgL mutation in the highly mucoid CF isolate FRD1.
47  algZ deletion mutant was constructed in the mucoid CF isolate FRD1.
48  the secretion is triggered primarily in the mucoid CF isolate of strain 8821M (or in strain FRD1) bu
49                                    A typical mucoid CF isolate, FRD1, and its isogenic mutants were t
50 The overall frequency of mucA alterations in mucoid CF isolates was 84%.
51               The mucA22 allele is common in mucoid CF isolates.
52  90% reduction in alginate production in the mucoid, CF isolate, P. aeruginosa FRD1.
53 ariner transposon library using CF149, a non-mucoid clinical isolate with a misssense mutation in alg
54 r, the average amount of cyanide produced by mucoid clinical isolates was 4.7 +/- 0.85 micromol of HC
55 increase in bacterial hyaluronan production (mucoid colonies 200 mug per CFU and no detectable capsul
56 tified as csrR, caused the strain to produce mucoid colonies and to increase transcription of hasA, t
57 ive ("flesh-eating") infection often grow as mucoid colonies on primary culture but lose this colony
58  no detectable capsule production in the non-mucoid colonies).
59 between small, dry, compact and larger, more mucoid colonies.
60 ooth colony (SM) switches to a more virulent mucoid colony (MC) variant.
61 23.7%) isolates lacked the typical button or mucoid colony appearance of S. pneumoniae.
62 syrA was identified by its ability to confer mucoid colony morphology and by its ability to suppress
63 solates from these patients typically have a mucoid colony morphology due to overproduction of the ex
64 3 produced a transconjugant that exhibited a mucoid colony morphology, reflecting increased hyaluroni
65  the exopolysaccharide alginate resulting in mucoid colony morphology.
66 The hldD, hldE, and waaF mutants exhibited a mucoid colony phenotype due to production of a colanic a
67                             Organisms with a mucoid colony phenotype when grown on blood agar plates
68 lymer poly-gamma-glutamate (PGA) to confer a mucoid colony phenotype.
69 a usually undergoes a phenotypic switch to a mucoid colony, which is characterized by the overproduct
70 h cells from smooth-colony variants (SM) and mucoid-colony variants (MC) arising from phenotypic swit
71                   These results suggest that mucoid conversion and inhibition of invasive virulence d
72                                 However, the mucoid conversion can occur in wt mucA strains via the d
73            These observations suggested that mucoid conversion in CF may be driven by a selection for
74  that reducing activity of RpoD is linked to mucoid conversion in CF149.
75 omoter caused the overexpression of MucE and mucoid conversion in P. aeruginosa strains PAO1 and PA14
76 ion of the exopolysaccharide alginate causes mucoid conversion in Pseudomonas aeruginosa and is a poo
77 coid isolation, increased exacerbations, and mucoid conversion in vivo.
78                                              Mucoid conversion is indicative of overproduction of a c
79           In this study we hypothesized that mucoid conversion may be part of a larger response that
80                Estradiol and estriol induced mucoid conversion of P. aeruginosa in women with cystic
81 th cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contr
82 e C terminus of MucE (WVF) were required for mucoid conversion via two predicted proteases AlgW (DegS
83   Thus, even though dsbA is coregulated with mucoid conversion, it was not required for alginate prod
84 n cystic fibrosis patients typically undergo mucoid conversion.
85 order to identify protein levels enhanced by mucoid conversion.
86 factor MucA is a well-accepted mechanism for mucoid conversion.
87 ationic polypeptide-depleted fluid against a mucoid cystic fibrosis isolate of P. aeruginosa.
88  we tested wild-type strains PAO1, PA14, the mucoid cystic fibrosis isolate, FRD1 (mucA22+), and the
89  show here that a null mutation in kinB in a mucoid cystic fibrosis isolate, P. aeruginosa FRD1, did
90 structure of microvessel walls, formation of mucoid cysts initiated in the proximity of damaged micro
91                              The severity of mucoid degeneration and chondroid metaplasia in the ACL
92 ar appearance, pronounced vacuolization, and mucoid degeneration, appearing as Wallerian degeneration
93 e found that P. aeruginosa strain PAO1 and a mucoid derivative of strain PAO1 each grew at dissolved
94  large fraction of P. aeruginosa CF isolates mucoid, did not abrogate AlgU-MucA interactions, althoug
95 iants of Cryptococcus neoformans (smooth and mucoid) differed in their abilities to promote increased
96 ns associated with cystic fibrosis are often mucoid due to the copious production of alginate, an exo
97                         lon mutants are also mucoid, due to the stabilization of another Lon substrat
98                             In addition, two mucoid E. faecalis isolates from patients with chronic u
99 r (TNF)-alpha, a proinflammatory cytokine in mucoid effusion, markedly increased Muc2 mucin mRNA expr
100                                          The mucoid exopolysaccharide (MEP) from P. aeruginosa has be
101 he opsonic antibody activity specific to the mucoid exopolysaccharide (MEP) surface antigen.
102 than those involved in the production of the mucoid exopolysaccharide alginate, are turned on during
103 aboration of the extracellular, O-acetylated mucoid exopolysaccharide, or alginate, is a major microb
104  upon the conversion of P. aeruginosa to the mucoid, exopolysaccharide alginate-overproducing phenoty
105                            The conversion to mucoid, exopolysaccharide alginate-overproducing phenoty
106      Similar experiments were performed with mucoid films collected from the inferior conjunctival fo
107 ular surface in DED patients and abundant in mucoid films.
108 use conversion from a typical nonmucoid to a mucoid form in the CF lung.
109                                  Among these mucoid forms, the 'houses' of larvaceans are marvels of
110 ix to eight times as intense as those of the mucoid FRD1 parent strain.
111 he algT-mucABCD operon, MucD was detected in mucoid (FRD1) and nonmucoid (PAO1) parental strains and
112                                         Four mucoid fur mutants produced 1.7- to 2.6-fold-greater fum
113 ignal intensities and the so-called inverted mucoid impaction signal (IMIS) sign was qualitatively an
114                                 This type of mucoid induction requires the alternate sigma factor Rpo
115  wild-type mice challenged with an LPS-rough mucoid isolate of P. aeruginosa lacking the CFTR ligand.
116                           In some instances, mucoid isolates of P. aeruginosa were recovered from lun
117                                              Mucoid isolates were more likely to be hypermutators.
118 ratory strains and early lung colonizing non-mucoid isolates with a wt mucA.
119                                 However, for mucoid isolates, correlation coefficients (r values) for
120  show greater expression of the gene than do mucoid isolates.
121  they were significantly less effective with mucoid isolates.
122 tro and were associated with selectivity for mucoid isolation, increased exacerbations, and mucoid co
123 y and proteomic analyses were performed on a mucoid kinB mutant and an isogenic nonmucoid kinB rpoN d
124 ction from laboratory isolates revealed that mucoid laboratory strains made sevenfold more HCN than t
125 gulated using isogenic S. aureus MN8 and MN8 mucoid (MN8m) strains, the latter of which constitutivel
126 atients with cystic fibrosis often display a mucoid morphology due to high levels of expression of th
127 re to estradiol, P. aeruginosa adopted early mucoid morphology, whereas short-term exposure inhibited
128 romoter of rpoH was found to be activated in mucoid mucA mutants.
129                       Alginate production in mucoid (MucA-defective) Pseudomonas aeruginosa is depend
130                                              Mucoid, mucA mutant Pseudomonas aeruginosa cause chronic
131          When isogenic nonmucoid (mucA+) and mucoid (mucA22) P. aeruginosa strains were compared, the
132           However, inactivation of algZ in a mucoid mutant P. aeruginosa strain, which had AlgU freed
133                 Compared with MGAS166, these mucoid mutants are more hemolytic and cause significantl
134                                        Three mucoid mutants were identified with transposon insertion
135 ts showed that ectopic expression of FleQ in mucoid, nonmotile CF isolates restored flagellum biosynt
136 that AlgT inhibits flagellum biosynthesis in mucoid, nonmotile P. aeruginosa cystic fibrosis isolates
137  a repressor of fleQ, we mutated amrZ in the mucoid, nonmotile P. aeruginosa strain FRD1.
138 ntation of the mutant with amrZ restored the mucoid, nonmotile phenotype.
139 he cystic fibrosis lung frequently display a mucoid, nonmotile phenotype.
140 ibits lawn bordering and roaming behavior on mucoid nonpathogenic bacteria and loss of pathogen avoid
141 charge was frequent or very frequent in 85%, mucoid or mucopurulent in 90%, and moderate to severe in
142 hose in desert tortoises and include serous, mucoid, or purulent discharge from the nares, excessive
143                                              Mucoid otitis media (MOM) is characterized by viscous fl
144          CF cells sequentially infected with mucoid P. aeruginosa (MPA) and RV showed lower levels of
145 tor was also associated with reduced odds of mucoid P. aeruginosa (OR, 0.77; P = .013) and Aspergillu
146 ction chromatography of the crude extract of mucoid P. aeruginosa 8821, a CF isolate.
147 nse of cystic fibrosis and wild-type mice to mucoid P. aeruginosa administered by insufflation.
148 ntion of active elastase in the periplasm of mucoid P. aeruginosa and its role in the generation of t
149 sponse regulators activate alginate genes in mucoid P. aeruginosa appears not to be mediated by conve
150 l therapeutics directed against biofilms and mucoid P. aeruginosa are being developed.
151  it may play an important role in protecting mucoid P. aeruginosa biofilm bacteria from the human imm
152 ture and extracellular matrix composition of mucoid P. aeruginosa biofilms, through increased express
153                                         Thus mucoid P. aeruginosa cells elaborate enzymes that modula
154 creted into the extracellular environment by mucoid P. aeruginosa cells.
155  identified a protein(s), AlgZ, expressed in mucoid P. aeruginosa CF isolates that specifically bound
156  The calcium-induced extracellular matrix of mucoid P. aeruginosa consists primarily of the virulence
157 o the important clinical goal of eradicating mucoid P. aeruginosa from the CF airways.
158  investigated mechanisms of the emergence of mucoid P. aeruginosa in CF by analyzing the status of mu
159                             The emergence of mucoid P. aeruginosa in CF is associated with increased
160                             The emergence of mucoid P. aeruginosa in CF is associated with respirator
161 ing to the morbidity and mortality caused by mucoid P. aeruginosa in CF.
162 ung infections could not be established with mucoid P. aeruginosa in either cystic fibrosis or wild-t
163 fection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis
164 on of antibodies mediated opsonic killing of mucoid P. aeruginosa in vitro.
165     Indeed, chronic infection of the lung by mucoid P. aeruginosa is a major cause of morbidity and m
166              A mutation in the algR2 gene of mucoid P. aeruginosa is known to exhibit a nonmucoid (no
167 hesis by laboratory and clinical isolates of mucoid P. aeruginosa is necessary and sufficient to atte
168 airway epithelia to the stimuli presented by mucoid P. aeruginosa is not proinflammatory and, hence,
169 lyzing the status of mucA in a collection of mucoid P. aeruginosa isolates from 53 CF patients.
170           Comparison of paired nonmucoid and mucoid P. aeruginosa isolates from three CF patients ind
171                               Interestingly, mucoid P. aeruginosa isolates from urinary tract infecti
172 enance of biofilms produced by nonmucoid and mucoid P. aeruginosa isolates.
173 rogated AIgU-dependent rpoH transcription in mucoid P. aeruginosa laboratory isolates and CF isolates
174 pared with wild-type controls in the face of mucoid P. aeruginosa lung infection.
175 in CF is the result of a global induction in mucoid P. aeruginosa of lipoproteins that act as proinfl
176                   Our data indicate that (i) mucoid P. aeruginosa regardless of their origin (laborat
177 Transcriptional profiling analyses comparing mucoid P. aeruginosa strains to their isogenic algR dele
178 tibility testing of CF strains, particularly mucoid P. aeruginosa strains, is unknown.
179 ere similar in mice exposed to nonmucoid and mucoid P. aeruginosa throughout the infection.
180 tion of alginate maximizes the resistance of mucoid P. aeruginosa to antibody-independent opsonic kil
181 te plays an important role in the ability of mucoid P. aeruginosa to form biofilms and to resist comp
182 is the molecular basis for the resistance of mucoid P. aeruginosa to normally nonopsonic but alginate
183 ds or beads containing a clinical isolate of mucoid P. aeruginosa were instilled in the right lung of
184          We have previously reported that in mucoid P. aeruginosa, an intracellular protease cleaves
185          The recognition of genes induced in mucoid P. aeruginosa, other than those associated with a
186 ng that AlgR activates hcnA transcription in mucoid P. aeruginosa.
187 lobal responses to infection with motile and mucoid P. aeruginosa.
188  when the bulk of alginate is synthesized by mucoid P. aeruginosa.
189                  Elastase is secreted in non-mucoid P. aeruginosa.
190  patients, encounters alginate elaborated by mucoid P. aeruginosa.
191 isk factors, only respiratory infection with mucoid PA correlated significantly with bronchiectasis (
192  isolates were more likely to be infected by mucoid PA, and they showed a narrow T-cell epitope respo
193 cantly related to respiratory infection with mucoid PA; attempts to prevent bronchiectasis should inc
194                    Disruption of dsbA in the mucoid PDO300 background did not affect alginate product
195 Overexpression of algW in PAO1 resulted in a mucoid phenotype and alginate production, even in the ab
196 tion of phpA was found to correlate with the mucoid phenotype and an increase in algD transcription i
197  system that, when inactivated, results in a mucoid phenotype and enhanced virulence in mouse infecti
198 biofilms and the selection of mutants with a mucoid phenotype are major adaptations that allow its pe
199  conversion of Pseudomonas aeruginosa to the mucoid phenotype coincides with the establishment of chr
200 ion of invasive virulence factors and have a mucoid phenotype due to the production of an alginate ca
201                            The conversion to mucoid phenotype in Pseudomonas aeruginosa during chroni
202                                          The mucoid phenotype indicates alginate overproduction and i
203                                          The mucoid phenotype is due to abundant production of the hy
204 well-studied mechanism for transition to the mucoid phenotype is mutation of mucA, leading to loss of
205 regulator of both sigma(22) activity and the mucoid phenotype is the cognate anti-sigma factor MucA.
206  we demonstrated that in vivo switching to a mucoid phenotype occurred in two mice strains and was as
207 ere identified as positive regulators of the mucoid phenotype on PIAAMV.
208  Conversion of Pseudomonas aeruginosa to the mucoid phenotype plays a major role in the pathogenesis
209                                          The mucoid phenotype results from loss-of-function mutations
210          The alginate-overproducing (Alg(+)) mucoid phenotype seen in the CF isolates is extremely un
211 rity, and in the concomitant appearance of a mucoid phenotype that is reminiscent of cells in the ear
212 y have negative effects on expression of the mucoid phenotype under the conditions tested.
213                             Reversion to the mucoid phenotype was associated with reversion of the mu
214 The algXDelta::Gm mutant was restored to the mucoid phenotype with wild-type P. aeruginosa algX provi
215 opolysaccharide abundance (contributing to a mucoid phenotype).
216 riant was experimentally proven to cause the mucoid phenotype, and corresponding resistance to phagoc
217  the host immune system, and conversion to a mucoid phenotype.
218 s, P. aeruginosa undergoes a conversion to a mucoid phenotype.
219 saccharide, alginate, giving these strains a mucoid phenotype.
220 ause alginate overproduction, resulting in a mucoid phenotype.
221 tic susceptibility, capsule composition, and mucoid phenotype.
222 lginate, an exopolysaccharide that confers a mucoid phenotype.
223 ss of O-antigen synthesis alternating with a mucoid phenotype.
224 kground was constructed, and it showed a non-mucoid phenotype.
225 classic feature of CF airway isolates is the mucoid phenotype.
226  P. aeruginosa strains PAO1 and PA14 are non-mucoid, producing minimal amounts of alginate.
227 enBank database with only weak similarity to mucoid protein sequences.
228                               In conclusion, mucoid Pseudomonas adapted to the CF-lung remained able
229 [FEV(1)]) of the CFTR gene genotype, gender, mucoid Pseudomonas aeruginosa (MPA) infection status, pr
230                                              Mucoid Pseudomonas aeruginosa (n = 12; 15%) and nontuber
231 iated with chronic pulmonary infections with mucoid Pseudomonas aeruginosa (PA).
232 tics, tobramycin and ciprofloxacin, into non-mucoid Pseudomonas aeruginosa biofilms.
233 fficacy of azithromycin in a murine model of mucoid Pseudomonas aeruginosa endobronchial infection.
234  maintenance of chronic lung infections with mucoid Pseudomonas aeruginosa in patients with cystic fi
235  The exopolysaccharide alginate, produced by mucoid Pseudomonas aeruginosa in the lungs of cystic fib
236 tible to chronic pulmonary disease caused by mucoid Pseudomonas aeruginosa strains that overproduce t
237                                       In non-mucoid Pseudomonas aeruginosa strains, the Pel and Psl p
238 ciated with chronic pulmonary infection with mucoid Pseudomonas aeruginosa.
239 c bacteria and loss of pathogen avoidance on mucoid Pseudomonas aeruginosa.
240 tors in nontypeable, alginate overproducing (mucoid) Pseudomonas aeruginosa strains isolated from cys
241  we screened a transposon library in the non-mucoid reference strain PAO1, and identified a mutant th
242  were found to display phenotypes which were mucoid relative to the phenotype of the parental algB st
243 s been attributed to accumulation of viscous mucoid secretions in intrahepatic bile ducts.
244 hrough viscoelastic cervical mucus and other mucoid secretions to reach the site of fertilization.
245      By using a representative strain of the mucoid serotype 3 clone, rough phase variants with a div
246 ations were found to be strain specific: the mucoid strain 18A experienced mutations in alginate prod
247 ies from isogenic nonmucoid strain 4095a and mucoid strain 4095c were further investigated.
248  whether these proteins were enhanced in the mucoid strain due to increased transcription.
249 genesis of nonmucoid algB derivatives of the mucoid strain FRD1 was employed.
250 gG activity, a mutant was constructed in the mucoid strain FRD1 with a defined non-polar deletion of
251                 Herein we show that a highly mucoid strain of E. coli K-12 ligates CA repeats to a si
252 on the eradication of biofilms formed by the mucoid strain of Pseudomonas aeruginosa and investigated
253 FU of group B streptococci or 10(7) CFU of a mucoid strain of Pseudomonas aeruginosa by intratracheal
254                                          For mucoid strain P. aeruginosa FRD1, calcium addition (1.0
255 eatment with S-nitrosoglutathione, while the mucoid strain PAO578II showed no further upregulation ab
256 pted agar bead murine model using a clinical mucoid strain that demonstrates the key features of tran
257 teins that were clearly more abundant in the mucoid strain were observed.
258                                 However, the mucoid strains can revert to nonmucoidy in vitro through
259                                          Non-mucoid strains can use either Pel or Psl as the primary
260 tions are cleared but chronic infection with mucoid strains ensues in the majority of CF patients and
261                           Here, we show that mucoid strains of bacteria that produce an exopolysaccha
262                           In the presence of mucoid strains of bacteria, the C. elegans laboratory wi
263                    However, certain clinical mucoid strains of P. aeruginosa have a wild-type (wt) mu
264 odies broadly cross-reactive to heterologous mucoid strains of P. aeruginosa.
265  an extracellular polysaccharide produced by mucoid strains of Pseudomonas aeruginosa that are typica
266                          The second were the mucoid strains Smith diffuse and M, both of which encode
267 on resulted in suppression of mucoidy in all mucoid strains tested, indicating that sigma factor comp
268 ent promoter (PssrA ) was more active in non-mucoid strains than in isogenic mucoid variants.
269 l), is required for biofilm formation in non-mucoid strains that do not rely on alginate as the princ
270 uggests that the reduced CBC observed in the mucoid strains was due to masking of the collagen adhesi
271 ) of nonmucoid strains and 40% (24 of 60) of mucoid strains were definitively identified as Pseudomon
272 n were non-CF strains (P < 0.0001), although mucoid strains were not more likely to have serious disc
273                                              Mucoid strains with mucA mutations predominantly populat
274 enhanced or reduced formation of alginate in mucoid strains, respectively.
275 tL lineage was replaced after 11 days by non-mucoid strains.
276 ved from Pseudomonas lipoproteins induced in mucoid strains.
277 d the presence of mucA mutations only in the mucoid strains.
278    MAb-reactive (nonmucoid) and nonreactive (mucoid) strains from the same patient exhibited identica
279 onic acid capsule on highly encapsulated, or mucoid, strains.
280               In the midwaters of the ocean, mucoid structures are readily secreted by numerous anima
281         However, little is known about these mucoid structures owing to the challenges of observing t
282           Selection of both pre-existing non-mucoid subpopulations and of novel phenotypic traits sug
283                      Similar to cells of the mucoid switch variant, all1Delta cells produced a larger
284 und to be downregulated in the hypervirulent mucoid switch variant, both during logarithmic growth an
285  mimicked the hypervirulent phenotype of the mucoid switch variant, which is characterized by decreas
286 hese mutants ranged from being only slightly mucoid to being indistinguishable from that of the origi
287                      One of the particularly mucoid transposon mutants was chosen for further study.
288 erotype 19 gives rise to variants (the small mucoid variant [SMV] and the acapsular small-colony vari
289                       Rats infected with the mucoid variant developed increased ICP, whereas rats inf
290                                    The large mucoid variant formed flat unstructured biofilms, failed
291 brain fungal burdens were comparable between mucoid variant- and smooth parent-infected rats.
292  cerebrospinal fluid (CSF) fungal burden for mucoid variant-infected rats, although brain fungal burd
293 intensity over the surfaces of the brains of mucoid variant-infected rats.
294 charide accumulated in the CSF and brains of mucoid variant-infected rats.
295 tic inflammatory response in the meninges of mucoid variant-infected rats.
296                                              Mucoid variants appeared at later biofilm developmental
297                                              Mucoid variants of the opportunistic pathogen Pseudomona
298                 Low oxygen tension growth of mucoid variants readily selects for nonmucoid variants.
299 ctive in non-mucoid strains than in isogenic mucoid variants.
300                             In contrast, the mucoid wild-type strain produced only polymerized uronic

 
Page Top